Insider Selling: Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Sells 1,744 Shares of Stock

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) Senior Officer Eric Bentz sold 1,744 shares of Jamieson Wellness stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of C$28.62, for a total value of C$49,912.76.

Jamieson Wellness Stock Performance

JWEL stock traded down C$1.01 during midday trading on Tuesday, hitting C$28.24. 121,016 shares of the company traded hands, compared to its average volume of 90,247. The stock has a market capitalization of C$1.18 billion, a price-to-earnings ratio of 29.67 and a beta of 0.63. The business has a 50 day simple moving average of C$32.93 and a 200-day simple moving average of C$34.14. The company has a quick ratio of 1.08, a current ratio of 2.76 and a debt-to-equity ratio of 75.70. Jamieson Wellness Inc. has a twelve month low of C$23.98 and a twelve month high of C$38.20.

Jamieson Wellness Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, March 14th will be paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 2.97%. The ex-dividend date of this dividend is Friday, March 7th. Jamieson Wellness's dividend payout ratio is 88.26%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on JWEL. BMO Capital Markets increased their target price on shares of Jamieson Wellness from C$42.00 to C$46.00 in a report on Thursday, December 19th. National Bankshares raised their price target on shares of Jamieson Wellness from C$36.50 to C$42.00 in a research note on Monday, November 25th. Finally, Royal Bank of Canada boosted their price objective on Jamieson Wellness from C$38.00 to C$41.00 and gave the stock an "outperform" rating in a research report on Tuesday, February 25th.

Remove Ads

About Jamieson Wellness

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.